Cargando…
Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study
Background: Cancer patients are considered susceptible to coronavirus disease (COVID-19) due to an immunosuppressive state. This study determined the prevalence of cancer as a comorbid in COVID-19 patients, severe events, case fatality rate, history of anticancer therapy associated with severe event...
Autores principales: | Sitanggang, Johan S., Siregar, Kamal B., Sitanggang, Henry H., Sprinse Vinolina, Noverita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382154/ https://www.ncbi.nlm.nih.gov/pubmed/36051540 http://dx.doi.org/10.12688/f1000research.53539.2 |
Ejemplares similares
-
The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
por: Soeroso, Noni Novisari, et al.
Publicado: (2023) -
Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis
por: Alkhathami, Mohammed G., et al.
Publicado: (2021) -
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis
por: Gülsen, Askin, et al.
Publicado: (2021) -
Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis
por: Mishra, Pinki, et al.
Publicado: (2022) -
A Critical Analysis of Intracranial Hemorrhage as a Fatal Complication of Dengue Fever
por: Siahaan, Andre Marolop Pangihutan, et al.
Publicado: (2023)